Clinical Trial Update: Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial updating the efficacy and safety of eletriptan for treating migraine in patients not satisfied with rizatriptan therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Eletriptan (eletriptan)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Migraine | Phase 4 | Status: COMPLETED